These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 4773114)

  • 21. Measurement of surface color as an expedient QC method for the detection of deviations in tablet hardness.
    Siddiqui A; Nazzal S
    Int J Pharm; 2007 Aug; 341(1-2):173-80. PubMed ID: 17499947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of rapidly disintegrating tablets manufactured by phase transition of sugar alcohols.
    Kuno Y; Kojima M; Ando S; Nakagami H
    J Control Release; 2005 Jun; 105(1-2):16-22. PubMed ID: 15955365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study of tablets. IV. Influence of the nature and proportion of some adjuvants on phenobarbital grain and tablet qualities].
    Clerc J; Duchêne D; Puisieux F
    Ann Pharm Fr; 1970 Dec; 28(12):719-28. PubMed ID: 5516406
    [No Abstract]   [Full Text] [Related]  

  • 24. A study of the plasma levels of pentaerythritol mononitrate following administration of pentaerythritol tetranitrate in combination with meprobamate and diphenhydramine.
    Gilbert JD; Aylott RI; Draffan GH; Sögtrop HH
    Arzneimittelforschung; 1982; 32(5):571-4. PubMed ID: 7201836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utilization of hydrophilic gums for the control of drug substance release from tablet formulations. II. Influence of tablet hardness and density on dissolution behavior.
    Huber HE; Christenson GL
    J Pharm Sci; 1968 Jan; 57(1):164-7. PubMed ID: 5652122
    [No Abstract]   [Full Text] [Related]  

  • 26. Aspirin, absorption rate and analgesic effect.
    Levy G
    Anesth Analg; 1965; 44(6):837-41. PubMed ID: 5891911
    [No Abstract]   [Full Text] [Related]  

  • 27. Plasma concentrations after oral administration of different pharmaceutical preparations of clomethiazole.
    Fischler M; Frisch EP; Ortengren B
    Acta Pharm Suec; 1973 Dec; 10(6):483-92. PubMed ID: 4773115
    [No Abstract]   [Full Text] [Related]  

  • 28. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
    Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
    Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The interaction between cholestyramine and drugs.
    Gallo DG; Bailey KR; Sheffner AL
    Proc Soc Exp Biol Med; 1965 Oct; 120(1):60-5. PubMed ID: 5852732
    [No Abstract]   [Full Text] [Related]  

  • 30. [Influence of some lubricants on the stability of aspirin in tablet form].
    Jaminet F; Louis G
    Pharm Acta Helv; 1968 Mar; 43(3):153-7. PubMed ID: 5720084
    [No Abstract]   [Full Text] [Related]  

  • 31. Abrasion of tablets during scale-up: the influence of different crushing forces in laboratory and production perforated pan coaters.
    Mueller R; Kleinebudde P
    Eur J Pharm Biopharm; 2007 Sep; 67(2):458-63. PubMed ID: 17475452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Biopharmaceutical studies on meprobamate tables formulation (author's transl].
    Aiache JM; Andermann G
    J Pharm Belg; 1978; 33(3):157-70. PubMed ID: 682102
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacokinetic and pharmacodynamic studies following oral administration of erythropoietin mucoadhesive tablets to beagle dogs.
    Venkatesan N; Yoshimitsu J; Ohashi Y; Ito Y; Sugioka N; Shibata N; Takada K
    Int J Pharm; 2006 Mar; 310(1-2):46-52. PubMed ID: 16439074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formulation design of a novel fast-disintegrating tablet.
    Mizumoto T; Masuda Y; Yamamoto T; Yonemochi E; Terada K
    Int J Pharm; 2005 Dec; 306(1-2):83-90. PubMed ID: 16257154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioavailability of the acetylsalicylic acid tablets registered in Finland.
    Perälä-Suominen A
    Ann Clin Res; 1974; 6(0):suppl 11:26-33. PubMed ID: 4855462
    [No Abstract]   [Full Text] [Related]  

  • 36. Aspirin.
    Scopp IW; Roehrl PL
    N Y J Dent; 1979; 49(7):218-20. PubMed ID: 287960
    [No Abstract]   [Full Text] [Related]  

  • 37. Bioavailability studies on a buffered acetylsalicylic acid preparation.
    Ekenved G; Elofsson R; Sölvell L
    Acta Pharm Suec; 1975; 12(4):323-32. PubMed ID: 1106118
    [No Abstract]   [Full Text] [Related]  

  • 38. The influence of compression and formulation on the hardness, disintegration, dissolution, absorption and excretion of sulphadimidine tablets.
    van Oudtshoorn MC; Potgieter FJ; de Blaey CJ; Polderman J
    J Pharm Pharmacol; 1971 Aug; 23(8):583-6. PubMed ID: 4397740
    [No Abstract]   [Full Text] [Related]  

  • 39. Novel platens to measure the hardness of a pentagonal shaped tablet.
    Malladi J; Sidik K; Wu S; McCann R; Dougherty J; Parab P; Carragher T
    Pharm Dev Technol; 2017 Mar; 22(2):246-255. PubMed ID: 27607150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relative bioavailability of griseofulvin lyophilized dry emulsion tablet vs. immediate release tablet: a single-dose, randomized, open-label, six-period, crossover study in healthy adult volunteers in the fasted and fed states.
    Ahmed IS; Aboul-Einien MH; Mohamed OH; Farid SF
    Eur J Pharm Sci; 2008 Oct; 35(3):219-25. PubMed ID: 18675344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.